1 March 2020
Gero LLC, an AI-powered platform and a drug pipeline for drug discovery and drug repurposing focused on complex diseases and chronic age-related diseases, has signed an agreement to utilize pharmAI’s services to analyze protein-protein interaction along the line of its drug development services.
We are looking forward to a great partnering conference in Hamburg this year. Our CEO Joachim Haupt will present the unique Focused Library Service. With this technology, pharmAI has access to millions of chemical compounds sold be the most popular chemical library vendors.
If you attend BIO-EUROPE, we would be delighted to see you at our talk on Tuesday, November 12 11:00 AM room 3.